421 related articles for article (PubMed ID: 28386132)
41. Serological Protection 5-6 Years Post Vaccination Against Yellow Fever in African Infants Vaccinated in Routine Programmes.
Idoko OT; Domingo C; Tapia MD; Sow SO; Geldmacher C; Saathoff E; Kampmann B
Front Immunol; 2020; 11():577751. PubMed ID: 33133096
[No Abstract] [Full Text] [Related]
42. Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study.
Domingo C; Fraissinet J; Ansah PO; Kelly C; Bhat N; Sow SO; Mejía JE
Lancet Infect Dis; 2019 Dec; 19(12):1363-1370. PubMed ID: 31543249
[TBL] [Abstract][Full Text] [Related]
43. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
Barrett AD; Teuwen DE
Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
[TBL] [Abstract][Full Text] [Related]
44. Yellow fever vaccine: past, present and future.
Roukens AH; Visser LG
Expert Opin Biol Ther; 2008 Nov; 8(11):1787-95. PubMed ID: 18847312
[TBL] [Abstract][Full Text] [Related]
45. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria.
Monath TP; Nasidi A
Am J Trop Med Hyg; 1993 Feb; 48(2):274-99. PubMed ID: 8447531
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.
Gotuzzo E; Yactayo S; Córdova E
Am J Trop Med Hyg; 2013 Sep; 89(3):434-44. PubMed ID: 24006295
[TBL] [Abstract][Full Text] [Related]
47. Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice.
Tretyakova I; Nickols B; Hidajat R; Jokinen J; Lukashevich IS; Pushko P
Virology; 2014 Nov; 468-470():28-35. PubMed ID: 25129436
[TBL] [Abstract][Full Text] [Related]
48. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.
Akondy RS; Monson ND; Miller JD; Edupuganti S; Teuwen D; Wu H; Quyyumi F; Garg S; Altman JD; Del Rio C; Keyserling HL; Ploss A; Rice CM; Orenstein WA; Mulligan MJ; Ahmed R
J Immunol; 2009 Dec; 183(12):7919-30. PubMed ID: 19933869
[TBL] [Abstract][Full Text] [Related]
49. Long-Term Protection After Fractional-Dose Yellow Fever Vaccination: Follow-up Study of a Randomized, Controlled, Noninferiority Trial.
Roukens AHE; van Halem K; de Visser AW; Visser LG
Ann Intern Med; 2018 Dec; 169(11):761-765. PubMed ID: 30476963
[TBL] [Abstract][Full Text] [Related]
50. Validation of a yellow fever vaccine model using data from primary vaccination in children and adults, re-vaccination and dose-response in adults and studies with immunocompromised individuals.
Bonin CRB; Fernandes GC; de Menezes Martins R; Camacho LAB; Teixeira-Carvalho A; da Mota LMH; de Lima SMB; Campi-Azevedo AC; Martins-Filho OA; Dos Santos RW; Lobosco M;
BMC Bioinformatics; 2020 Dec; 21(Suppl 17):551. PubMed ID: 33308151
[TBL] [Abstract][Full Text] [Related]
51. Clinical evidence for the immunogenicity and immune persistence of vaccination with yellow fever virus strain 17D in Chinese peacekeepers deployed to Africa.
Jia Q; Jia C; Liu Y; Yang Y; Qi J; Tong L; Chen H; Zhang M; Che J; Li B; Li Z
Antiviral Res; 2019 Feb; 162():1-4. PubMed ID: 30529359
[TBL] [Abstract][Full Text] [Related]
52. Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease.
Barrett ADT
Vaccine; 2017 Oct; 35(44):5951-5955. PubMed ID: 28366605
[TBL] [Abstract][Full Text] [Related]
53. Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial.
Camacho LA; de Aguiar SG; Freire Mda S; Leal Mda L; do Nascimento JP; Iguchi T; Lozana JA; Farias RH;
Rev Saude Publica; 2005 Jun; 39(3):413-20. PubMed ID: 15997317
[TBL] [Abstract][Full Text] [Related]
54. Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination.
da Costa-Rocha IA; Machado KLLL; Campi-Azevedo AC; Teixeira-Carvalho A; Peruhype-Magalhães V; de Lima SMB; Miranda EH; Trindade GF; Casagrande TZ; Miyamoto ST; Deotti SC; Barbosa RVR; Rocha PCM; Serrano EV; Dinis VG; Gouvêa SA; Gavi MBRO; da Silva LB; Duque RH; Gianordoli APE; Bissoli MF; Gouvea MDPG; Pinto-Neto LFDS; Burian APN; Fantinato FFST; Pileggi GS; da Mota LMH; Valim V; Martins-Filho OA
Sci Rep; 2021 May; 11(1):10431. PubMed ID: 34001945
[TBL] [Abstract][Full Text] [Related]
55. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D
J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543
[TBL] [Abstract][Full Text] [Related]
56. Serologic assessment of yellow fever immunity in the rural population of a yellow fever-endemic area in Central Brazil.
Machado VW; Vasconcelos PF; Silva EV; Santos JB
Rev Soc Bras Med Trop; 2013; 46(2):166-71. PubMed ID: 23740066
[TBL] [Abstract][Full Text] [Related]
57. An inactivated cell-culture vaccine against yellow fever.
Monath TP; Fowler E; Johnson CT; Balser J; Morin MJ; Sisti M; Trent DW
N Engl J Med; 2011 Apr; 364(14):1326-33. PubMed ID: 21470010
[TBL] [Abstract][Full Text] [Related]
58. Duration of post-vaccination immunity against yellow fever in adults.
Collaborative group for studies on yellow fever vaccines
Vaccine; 2014 Sep; 32(39):4977-84. PubMed ID: 25090646
[TBL] [Abstract][Full Text] [Related]
59. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
Collaborative Group for Studies with Yellow Fever Vaccine
Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
[TBL] [Abstract][Full Text] [Related]
60. A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.
Calvert AE; Dixon KL; Piper J; Bennett SL; Thibodeaux BA; Barrett AD; Roehrig JT; Blair CD
Antiviral Res; 2016 Jul; 131():92-9. PubMed ID: 27126613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
